Predictive models for posttransplant diabetes mellitus in kidney transplant recipients using machine learning and deep learning approach: a nationwide cohort study from South Korea
Open Access
- 1 November 2025
- journal article
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 44 (6) , 984-995
Abstract
Background: Posttransplant diabetes mellitus (PTDM) complicates kidney transplant recipients (KTRs) in morbidity and mortality. This study aimed to predict PTDM risk in KTRs using machine learning and deep learning models. Methods: Data were obtained from the Korea Organ Transplantation Registry, a nationwide cohort study of KTRs. Four machine learning algorithms, including eXtreme Gradient Boosting (XGBoost), CatBoost, light gradient boosting machine and logistic regression, and deep learning were implemented on 41 pretransplant and 31 posttransplant variables to predict PTDM. Model performance was assessed using the area under the curve (AUC) of the receiver operating characteristic curve, accuracy, precision, recall, and F1 score. Results: Among 3,213 KTRs, 497 patients (15.5%) developed PTDM within 1 year. The PTDM group had higher age, body mass index (BMI), triglyceride level, and prevalence of hypertension and cardiovascular disease, and lower total cholesterol level at baseline than the No-PTDM group. The XGBoost model showed the highest AUC (0.738) and F1 score (0.42), and modest accuracy (0.86), while the CatBoost model exhibited the highest accuracy (0.87) and precision (0.79). Feature importance in XGBoost was highest for recipient age, followed by baseline BMI, triglyceride level at posttransplant 6 months, baseline glycated hemoglobin and high-density lipoprotein cholesterol level, white blood cell (WBC) count and serum uric acid level at 6 months, baseline WBC count, and tacrolimus trough level at discharge.Conclusion: The XGBoost model demonstrated the best performance for predicting PTDM within 1 year, offering an accurate tool for early identification and personalized care of high-risk KTRs for PTDM.Keywords
Funding Information
- Ministry of Health and Welfare (HI23C047600)
- Patient-Centered Clinical Research Coordinating Center
- Ministry of Health and Welfare (HI19C0481 and HC20C0054)
- National Institute of Health (2014-ER6301-00, 2014-ER6301-01, 2014-ER6301-02, 2017-ER6301-00, 2017-ER6301-01, 2017-ER6301-02, 2020-ER7201-00, 2020-ER7201-01, 2020-ER7201-02, 2023-ER0805-00, and 2023-ER0805-01)
This publication has 19 references indexed in Scilit:
- Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantationSaudi Pharmaceutical Journal, 2022
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without RaceNew England Journal of Medicine, 2021
- Applications of deep learning for the analysis of medical dataArchives of Pharmacal Research, 2019
- Post-transplant diabetes mellitus in patients with solid organ transplantsNature Reviews Endocrinology, 2019
- Post-transplantation diabetes in kidney transplant recipients: an update on management and preventionActa Diabetologica, 2018
- Post-transplantation diabetes—state of the artThe Lancet Diabetes & Endocrinology, 2016
- Clinical evolution of post-transplant diabetes mellitusNephrology Dialysis Transplantation, 2015
- Emerging treatments for post-transplantation diabetes mellitusNature Reviews Nephrology, 2015
- Complications associated with new-onset diabetes after kidney transplantationNature Reviews Nephrology, 2011
- Risk factors for new-onset diabetes after kidney transplantationNature Reviews Nephrology, 2010